Incannex Healthcare Inc. (NASDAQ: IXHL)
$2.57
+0.0200 ( +0.78% ) 28.1K
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.
Market Data
Open
$2.57
Previous close
$2.55
Volume
28.1K
Market cap
$44.81M
Day range
$2.39 - $2.67
52 week range
$0.80 - $12.68
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | May 30, 2024 |
10-q | Quarterly Reports | 78 | May 15, 2024 |
8-k | 8K-related | 15 | May 07, 2024 |
8-k | 8K-related | 15 | Apr 16, 2024 |
8-k | 8K-related | 16 | Mar 05, 2024 |
8-k | 8K-related | 17 | Feb 28, 2024 |
8-k | 8K-related | 16 | Feb 16, 2024 |
10-q | Quarterly Reports | 80 | Feb 14, 2024 |
8-k | 8K-related | 17 | Feb 01, 2024 |
8-k | 8K-related | 14 | Jan 24, 2024 |